Nanjing Reju Therapeutics Inc. has described tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) inhibitors reported to be useful for the treatment of inflammatory-related ...

Hello! I am both an Alumnus of CofC and a lifelong Charleston resident. In addition to being an academic advisor, I am also the Assistant Director for Peer Advising, managing our student advisors in ...